The pharmacokinetics and safety of darapladib in subjects with severe renal impairment

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2125|80|4|654-661

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.80, Iss.4, 2015-10, pp. : 654-661

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The pharmacokinetics and safety of darapladib in subjects with severe renal impairment

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 306-5251, Iss. 4, 2015-10 ,pp. : 654-661

John Wiley & Sons Inc

Access to resources Recommend Favorite

The pharmacokinetics and safety of idelalisib in subjects with moderate or severe hepatic impairment

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 8, 2015-08 ,pp. : 944-952

John Wiley & Sons Inc

Access to resources Recommend Favorite

Garenoxacin pharmacokinetics in subjects with renal impairment

By Krishna Gopal   Gajjar Diptee   Swan Suzanne   Marbury Thomas   Grasela Dennis M.   Wang Zaiqi  

Current Medical Research and Opinion, Vol. 23, Iss. 3, 2007-03 ,pp. : 649-657

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of the dual melatonin receptor agonist tasimelteon in subjects with hepatic or renal impairment

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 5, 2015-05 ,pp. : 525-533

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of Nintedanib in Subjects With Hepatic Impairment

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 3, 2018-03 ,pp. : 357-363

John Wiley & Sons Inc

Access to resources Recommend Favorite